$ATRC
AtriCure, Inc.

2021 Q2 Form 10-Q Financial Statement

#000132388521000044 Filed on August 05, 2021

View on sec.gov

Income Statement

Concept 2021 Q2 2020 Q2 2020 Q1
Revenue $71.38M $40.82M $53.23M
YoY Change 74.84% -30.7% -1.37%
Cost Of Revenue $17.30M $13.17M $14.34M
YoY Change 31.34% -12.28% 1.75%
Gross Profit $54.08M $27.65M $38.88M
YoY Change 95.55% -37.0% -2.48%
Gross Profit Margin 75.76% 67.74% 73.06%
Selling, General & Admin $56.96M $24.90M $42.75M
YoY Change 128.72% -34.34% 15.5%
% of Gross Profit 105.33% 90.05% 109.94%
Research & Development $12.20M $10.04M $11.59M
YoY Change 21.53% 2.37% 41.72%
% of Gross Profit 22.55% 36.29% 29.8%
Depreciation & Amortization $2.660M $2.460M $1.955M
YoY Change 8.13% 3.8% 12.1%
% of Gross Profit 4.92% 8.9% 5.03%
Operating Expenses $69.16M $34.94M $54.34M
YoY Change 97.93% -26.8% 20.24%
Operating Profit -$15.08M -$7.285M -$15.45M
YoY Change 106.96% 89.76% 190.49%
Interest Expense $1.197M $1.231M $1.228M
YoY Change -2.76% 40.05% 42.46%
% of Operating Profit
Other Income/Expense, Net -$14.00K $29.00K -$123.0K
YoY Change -148.28% -422.22% 14.95%
Pretax Income -$16.19M -$8.224M -$16.40M
YoY Change 96.8% 101.03% 194.49%
Income Tax $66.00K $12.00K $8.000K
% Of Pretax Income
Net Earnings -$16.25M -$8.236M -$16.41M
YoY Change 97.32% 100.83% 191.18%
Net Earnings / Revenue -22.77% -20.17% -30.83%
Basic Earnings Per Share -$0.36
Diluted Earnings Per Share -$0.36 -$197.8K -$424.4K
COMMON SHARES
Basic Shares Outstanding 45.04M shares 40.07M 40.05M
Diluted Shares Outstanding 45.04M shares

Balance Sheet

Concept 2021 Q2 2020 Q2 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $159.9M $232.5M $68.50M
YoY Change -31.24% 156.06% -31.91%
Cash & Equivalents $67.62M $88.52M $21.77M
Short-Term Investments $92.25M $144.0M $46.80M
Other Short-Term Assets $4.636M $3.800M $4.300M
YoY Change 22.0% 15.15% 19.44%
Inventory $37.61M $32.81M $32.06M
Prepaid Expenses
Receivables $33.84M $22.89M $22.13M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $235.9M $292.0M $127.0M
YoY Change -19.21% 99.31% -18.06%
LONG-TERM ASSETS
Property, Plant & Equipment $30.18M $30.24M $32.32M
YoY Change -0.2% 7.62% 19.5%
Goodwill $234.8M $234.8M $234.8M
YoY Change 0.0% 123.05% 123.05%
Intangibles $127.2M $128.9M $129.4M
YoY Change -1.3% 166.96% 165.31%
Long-Term Investments $69.77M $15.30M $0.00
YoY Change 356.01% 18.6%
Other Assets $488.0K $366.0K $474.0K
YoY Change 33.33% -22.62% -2.47%
Total Long-Term Assets $465.1M $412.2M $400.7M
YoY Change 12.84% 109.67% 118.56%
TOTAL ASSETS
Total Short-Term Assets $235.9M $292.0M $127.0M
Total Long-Term Assets $465.1M $412.2M $400.7M
Total Assets $701.1M $704.2M $527.7M
YoY Change -0.45% 105.24% 55.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.50M $12.47M $17.30M
YoY Change 32.32% -0.99% 66.77%
Accrued Expenses $32.44M $17.88M $18.16M
YoY Change 81.41% -10.06% 6.47%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $853.0K $800.0K $800.0K
YoY Change 6.63% 14.29% 33.33%
Total Short-Term Liabilities $67.43M $38.05M $39.07M
YoY Change 77.21% -3.5% 10.17%
LONG-TERM LIABILITIES
Long-Term Debt $43.67M $54.15M $58.32M
YoY Change -19.36% 59.81% 78.16%
Other Long-Term Liabilities $192.5M $182.2M $188.9M
YoY Change 5.66% 1093.24% 977.78%
Total Long-Term Liabilities $236.2M $236.4M $247.2M
YoY Change -0.07% 380.84% 391.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $67.43M $38.05M $39.07M
Total Long-Term Liabilities $236.2M $236.4M $247.2M
Total Liabilities $316.0M $287.4M $300.4M
YoY Change 9.96% 182.92% 203.19%
SHAREHOLDERS EQUITY
Retained Earnings -$363.5M -$306.8M -$298.6M
YoY Change 18.47% 19.51% 18.19%
Common Stock $748.7M $723.8M $526.3M
YoY Change 3.44% 45.21% 6.93%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $385.1M $416.9M $227.4M
YoY Change
Total Liabilities & Shareholders Equity $701.1M $704.2M $527.7M
YoY Change -0.45% 105.24% 55.97%

Cashflow Statement

Concept 2021 Q2 2020 Q2 2020 Q1
OPERATING ACTIVITIES
Net Income -$16.25M -$8.236M -$16.41M
YoY Change 97.32% 100.83% 191.18%
Depreciation, Depletion And Amortization $2.660M $2.460M $1.955M
YoY Change 8.13% 3.8% 12.1%
Cash From Operating Activities -$4.529M -$11.55M -$16.09M
YoY Change -60.79% -408.0% 19.71%
INVESTING ACTIVITIES
Capital Expenditures -$4.209M -$1.110M $1.832M
YoY Change 279.19% -59.64% 7.2%
Acquisitions
YoY Change
Other Investing Activities -$11.84M -$111.7M $19.16M
YoY Change -89.4% -6271.27% 50.51%
Cash From Investing Activities -$16.06M -$112.8M $17.33M
YoY Change -85.76% 12030.11% 57.31%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.821M 191.1M -7.834M
YoY Change -98.52% 11139.41% -12.66%
NET CHANGE
Cash From Operating Activities -4.529M -11.55M -16.09M
Cash From Investing Activities -16.06M -112.8M 17.33M
Cash From Financing Activities 2.821M 191.1M -7.834M
Net Change In Cash -17.77M 66.71M -6.717M
YoY Change -126.64% 1375.88% -41.65%
FREE CASH FLOW
Cash From Operating Activities -$4.529M -$11.55M -$16.09M
Capital Expenditures -$4.209M -$1.110M $1.832M
Free Cash Flow -$320.0K -$10.44M -$17.92M
YoY Change -96.93% -260.62% 18.3%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 atrc Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Amounts Acquired During Acquisition Related Contingent Consideration
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAmountsAcquiredDuringAcquisitionRelatedContingentConsideration
atrc Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Amounts Acquired During Acquisition Related Contingent Consideration
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityAmountsAcquiredDuringAcquisitionRelatedContingentConsideration
atrc Proceeds From Capital Grant
ProceedsFromCapitalGrant
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
dei Entity Central Index Key
EntityCentralIndexKey
0001323885
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-51470
dei Entity Registrant Name
EntityRegistrantName
AtriCure, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
34-1940305
dei Entity Address Address Line1
EntityAddressAddressLine1
7555 Innovation Way
dei Entity Address City Or Town
EntityAddressCityOrTown
Mason
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
45040
dei City Area Code
CityAreaCode
513
dei Local Phone Number
LocalPhoneNumber
755-4100
dei Security12b Title
Security12bTitle
Common Stock, $.001 par value
dei Trading Symbol
TradingSymbol
ATRC
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45882449
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67619000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41944000
CY2021Q2 us-gaap Short Term Investments
ShortTermInvestments
92246000
CY2020Q4 us-gaap Short Term Investments
ShortTermInvestments
202274000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1121000
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1096000
CY2021Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33835000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23146000
CY2021Q2 us-gaap Inventory Net
InventoryNet
37608000
CY2020Q4 us-gaap Inventory Net
InventoryNet
35026000
CY2021Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4636000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4347000
CY2021Q2 us-gaap Assets Current
AssetsCurrent
235944000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
306737000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
30175000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
28290000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2683000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1914000
CY2021Q2 us-gaap Long Term Investments
LongTermInvestments
69770000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
14178000
CY2021Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
127234000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
128199000
CY2021Q2 us-gaap Goodwill
Goodwill
234781000
CY2020Q4 us-gaap Goodwill
Goodwill
234781000
CY2021Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
488000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
440000
CY2021Q2 us-gaap Assets
Assets
701075000
CY2020Q4 us-gaap Assets
Assets
714539000
CY2021Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
16496000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12736000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32444000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27984000
CY2021Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
18493000
CY2020Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8417000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
67433000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
49137000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
43669000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
53435000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10540000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10969000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1833000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1180000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
192517000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
187424000
CY2021Q2 us-gaap Liabilities
Liabilities
315992000
CY2020Q4 us-gaap Liabilities
Liabilities
302145000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
90000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45881000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45881000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45346000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45346000
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
46000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
45000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
748644000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
742389000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-87000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
312000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-363520000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-330352000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
385083000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
412394000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
701075000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
714539000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71376000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40824000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130651000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94049000
CY2021Q2 us-gaap Cost Of Revenue
CostOfRevenue
17298000
CY2020Q2 us-gaap Cost Of Revenue
CostOfRevenue
13170000
us-gaap Cost Of Revenue
CostOfRevenue
32033000
us-gaap Cost Of Revenue
CostOfRevenue
27511000
CY2021Q2 us-gaap Gross Profit
GrossProfit
54078000
CY2020Q2 us-gaap Gross Profit
GrossProfit
27654000
us-gaap Gross Profit
GrossProfit
98618000
us-gaap Gross Profit
GrossProfit
66538000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12197000
CY2020Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10036000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23414000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21623000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
56958000
CY2020Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24903000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
106166000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
67654000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
69155000
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
34939000
us-gaap Operating Expenses
OperatingExpenses
129580000
us-gaap Operating Expenses
OperatingExpenses
89277000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-15077000
CY2020Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7285000
us-gaap Operating Income Loss
OperatingIncomeLoss
-30962000
us-gaap Operating Income Loss
OperatingIncomeLoss
-22739000
CY2021Q2 us-gaap Interest Expense
InterestExpense
1197000
CY2020Q2 us-gaap Interest Expense
InterestExpense
1231000
us-gaap Interest Expense
InterestExpense
2386000
us-gaap Interest Expense
InterestExpense
2459000
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
103000
CY2020Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
263000
us-gaap Investment Income Interest
InvestmentIncomeInterest
237000
us-gaap Investment Income Interest
InvestmentIncomeInterest
668000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
40000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-94000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-16185000
CY2020Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8224000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33071000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-24624000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
66000
CY2020Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
97000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16251000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
us-gaap Net Income Loss
NetIncomeLoss
-33168000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
CY2021Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2020Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.20
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.74
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.61
CY2021Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
45035000
CY2020Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
41649000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
44834000
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
40160000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-132000
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
174000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-163000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
111000
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
63000
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
101000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-236000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-49000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
275000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-399000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16251000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
us-gaap Net Income Loss
NetIncomeLoss
-33168000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16320000
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7961000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33567000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24582000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
227366000
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188958000
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
8499000
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
275000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-8236000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
412394000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
6256000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
416862000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
416862000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
391243000
CY2021Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
10160000
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-69000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-16251000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
385083000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
247343000
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
188958000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
5143000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
62000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-399000
us-gaap Net Income Loss
NetIncomeLoss
-33168000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
385083000
us-gaap Net Income Loss
NetIncomeLoss
-33168000
us-gaap Net Income Loss
NetIncomeLoss
-24644000
us-gaap Share Based Compensation
ShareBasedCompensation
13745000
us-gaap Share Based Compensation
ShareBasedCompensation
10577000
us-gaap Depreciation
Depreciation
3815000
us-gaap Depreciation
Depreciation
3925000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
965000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
977000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
249000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
282000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-52000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-97000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1206000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-127000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
5100000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-5046000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
472000
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
656000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10799000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-5127000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2707000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3402000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
308000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
7000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3571000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1970000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
4529000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-14841000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
571000
us-gaap Increase Decrease In Other Noncurrent Assets And Liabilities Net
IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet
-507000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-13849000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-27635000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
94817000
us-gaap Payments To Acquire Available For Sale Securities
PaymentsToAcquireAvailableForSaleSecurities
127069000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
147884000
us-gaap Proceeds From Sale And Maturity Of Available For Sale Securities
ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities
33732000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5539000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2944000
atrc Proceeds From Capital Grant
ProceedsFromCapitalGrant
800000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
47528000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-95481000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
188958000
atrc Repayments Of Debt And Finance Lease Obligation
RepaymentsOfDebtAndFinanceLeaseObligation
399000
atrc Repayments Of Debt And Finance Lease Obligation
RepaymentsOfDebtAndFinanceLeaseObligation
280000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
4000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
9010000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6889000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
16500000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12323000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-7889000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
183240000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-115000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-85000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
25675000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
60039000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
41944000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
28483000
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
67619000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
88522000
us-gaap Interest Paid Net
InterestPaidNet
2147000
us-gaap Interest Paid Net
InterestPaidNet
2195000
us-gaap Income Taxes Paid
IncomeTaxesPaid
128000
us-gaap Income Taxes Paid
IncomeTaxesPaid
282000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
529000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
525000
us-gaap Nature Of Operations
NatureOfOperations
<span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Nature of the Business</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">—The “Company” or “AtriCure” consists of AtriCure, Inc. and its wholly-owned subsidiaries. The Company is </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">a </span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management and sells its products to medical centers globally through its direct sales force and distributors.</span>
CY2021Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
12381000
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
11966000
CY2021Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
3599000
CY2020Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
2424000
CY2021Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
21628000
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
20636000
CY2021Q2 us-gaap Inventory Net
InventoryNet
37608000
CY2020Q4 us-gaap Inventory Net
InventoryNet
35026000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1807000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2770000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-18000
CY2020Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-371000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
312000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-158000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-87000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96000
CY2021Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-87000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-96000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7141000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6193000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13745000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10577000
us-gaap Use Of Estimates
UseOfEstimates
<p dir="ltr" style="font-family: 'Times New Roman', 'serif';font-size: 10pt;line-height: 108%;margin-bottom: .001pt;margin-left: 0;margin-right: 0;margin-top: 0;"><span style="white-space:pre-wrap; font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;"> </span></p><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: italic;font-weight: bold;margin: 0;padding: 0;">Use of Estimates</span><span style="white-space:pre-wrap; font-family: 'Times New Roman', 'serif';font-size: 10pt;font-style: normal;font-weight: normal;margin: 0;padding: 0;">—The preparation of the financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, including intangible assets, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expense during the reporting period. Estimates are based on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results could differ from those estimates.</span>
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
184800000
CY2019Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
185157000
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
-5100000
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
357000
CY2021Q2 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
189900000
CY2020Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
184800000
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
138012000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10778000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
138012000
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
9813000
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
727000
CY2020Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
488000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
965000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
977000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
1943000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
3653000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
2953000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
2953000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
2953000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
30479000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
44934000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
17730000
CY2021Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
27036000
CY2021Q2 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
2579000
CY2020Q4 atrc Sales Returns Allowance Trade
SalesReturnsAllowanceTrade
1889000
CY2021Q2 us-gaap Taxes Payable Current
TaxesPayableCurrent
1616000
CY2020Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1256000
CY2021Q2 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
827000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
703000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
362000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
406000
CY2021Q2 atrc Accrued Settlement Current
AccruedSettlementCurrent
24000
CY2020Q4 atrc Accrued Settlement Current
AccruedSettlementCurrent
6000000
CY2021Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
32444000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
27984000
atrc Amended Loan Payment Deferral Period
AmendedLoanPaymentDeferralPeriod
P6M
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
6667000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
20000000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
20000000
CY2021Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
13333000
CY2021Q2 atrc Cash Payment Obligations On Debt Current
CashPaymentObligationsOnDebtCurrent
16667000
CY2021Q2 atrc Cash Payment Obligations On Debt Noncurrent
CashPaymentObligationsOnDebtNoncurrent
43333000
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
60000000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y6M
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y2M12D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0561
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0568
CY2021Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y1M6D
CY2020Q4 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y8M12D
CY2021Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0691
CY2020Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0691
CY2015Q4 us-gaap Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
1250000
CY2021Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
203000
CY2020Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
340000
us-gaap Operating Lease Cost
OperatingLeaseCost
481000
us-gaap Operating Lease Cost
OperatingLeaseCost
690000
CY2021Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
242000
CY2020Q2 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
263000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
484000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
526000
CY2021Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
200000
CY2020Q2 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
212000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
403000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
428000
CY2021Q2 us-gaap Lease Cost
LeaseCost
442000
CY2020Q2 us-gaap Lease Cost
LeaseCost
475000
us-gaap Lease Cost
LeaseCost
887000
us-gaap Lease Cost
LeaseCost
954000
us-gaap Operating Lease Payments
OperatingLeasePayments
494000
us-gaap Operating Lease Payments
OperatingLeasePayments
666000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
403000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
428000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
399000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
280000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1221000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1691000
us-gaap Gain Loss On Contract Termination
GainLossOnContractTermination
2473000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2683000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1914000
CY2021Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
973000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
927000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1833000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1180000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2806000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2107000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
14650000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization
14659000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
5570000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization
5247000
CY2021Q2 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9080000
CY2020Q4 us-gaap Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization
PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
9412000
CY2021Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
853000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
823000
CY2021Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10540000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
10969000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
11393000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
11792000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
415000
CY2021Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
806000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
895000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1629000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
688000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1652000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
615000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
1674000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
354000
CY2021Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
1625000
CY2021Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
8172000
CY2021Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2967000
CY2021Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
15558000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
161000
CY2021Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4165000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2806000
CY2021Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
11393000
atrc Number Of Royalty Agreements
NumberOfRoyaltyAgreements
1
CY2021Q2 us-gaap Royalty Expense
RoyaltyExpense
842000
CY2020Q2 us-gaap Royalty Expense
RoyaltyExpense
505000
us-gaap Royalty Expense
RoyaltyExpense
1564000
us-gaap Royalty Expense
RoyaltyExpense
1181000
us-gaap Long Term Purchase Commitment Amount
LongTermPurchaseCommitmentAmount
5500000
CY2021Q1 us-gaap Loss Contingency Damages Paid Value
LossContingencyDamagesPaidValue
6000000
CY2020Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
6000000
atrc Terms Of Sale For End Users
TermsOfSaleForEndUsers
P30D
atrc Terms Of Sale For Distributors
TermsOfSaleForDistributors
P60D
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0041
CY2020Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0015
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0029
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0008
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
atrc Share Based Compensation Arrangement By Share Based Payment Award Number Of Share Based Incentive Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfShareBasedIncentivePlans
2
atrc Total Shareholder Return Period
TotalShareholderReturnPeriod
P20D
atrc Total Shareholder Return Period
TotalShareholderReturnPeriod
P20D
atrc Employee Stock Purchase Plan Offer Period
EmployeeStockPurchasePlanOfferPeriod
P6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Maximum Number Of Shares Per Employee
ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee
3000
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7141000
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6193000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13745000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10577000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
71376000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
40824000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
130651000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
94049000

Files In Submission

Name View Source Status
0001323885-21-000044-index-headers.html Edgar Link pending
0001323885-21-000044-index.html Edgar Link pending
0001323885-21-000044.txt Edgar Link pending
0001323885-21-000044-xbrl.zip Edgar Link pending
atrc-20210630.xsd Edgar Link pending
atrc-20210630x10q.htm Edgar Link pending
atrc-20210630x10q_htm.xml Edgar Link completed
atrc-20210630xex31_1.htm Edgar Link pending
atrc-20210630xex31_2.htm Edgar Link pending
atrc-20210630xex32_1.htm Edgar Link pending
atrc-20210630xex32_2.htm Edgar Link pending
atrc-20210630_cal.xml Edgar Link unprocessable
atrc-20210630_def.xml Edgar Link unprocessable
atrc-20210630_lab.xml Edgar Link unprocessable
atrc-20210630_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending